Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men. - Wikidata - awgldk - TriplyDB

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

http://www.wikidata.org/entity/Q37604517

about

Pharmacological treatments for acute hepatitis C infection: a network meta-analysis Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?New treatments for genotype 1 chronic hepatitis C - focus on simeprevir Hepatitis C.Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.Hepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection Treatment HCV and HIV co-infection: mechanisms and management.A case of erythrodermia from exacerbated psoriasis vulgaris due to treatment of acute hepatitis C.Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.SASLT guidelines: Update in treatment of Hepatitis C virus infection.Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment.Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy.How will we manage acute HCV in men having sex with men in the era of all oral therapy?Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.Acute HCV in HIV-infected MSM: modes of acquisition, liver fibrosis, and treatment.Advances in the management of HIV/HCV coinfection.Sofosbuvir in the treatment of early HCV infection in HIV-infected men.Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.Successful treatment of sexually acquired acute HCV reinfection with ledipasvir/sofosbuvir in a HIV-infected patient.Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study.Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failure.Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome.Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infection.Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases.Consequence of HIV and HCV co-infection on host immune response, persistence and current treatment options.Ledipasvir and Sofosbuvir in the Treatment of Early Hepatitis C Virus Infection in HIV-Infected Men

P2860

Q24186859-C64A1BD0-B520-4FA1-A5D1-C702D813618E Q26798469-FA842BD5-A4FE-4ED2-A5BD-D4CB0682E849 Q26853138-99A914CC-1537-4F1C-A798-C6FFC0E7EDFD Q28084654-0EE8D727-C30E-477A-AFD7-E2D98A083422 Q30355190-3E7BB186-33EE-4D82-B89F-697E076149BC Q33576161-4491FEE8-5EA5-491A-9B66-1965C66DB3A7 Q35090634-8133CFB1-19B4-4779-9EBD-F68B454C8DF5 Q36031470-1AA5A986-DA00-4870-8DAE-F91369BB0B7C Q36123263-E6556F3C-98AE-4B47-9C70-617300ABDCD5 Q36330435-1DE73B98-DCD6-4E26-AC99-81A1A8188D2E Q37216507-40A6D972-1C60-4A62-A766-222E8969E343 Q38195262-B54B3DEE-AE47-41C0-9A10-9D2045076AE0 Q38206215-3610EBF2-9BEA-4DE2-ADD1-9ED399D1C62C Q38261733-B17C572E-1A5D-4730-B49F-1BDADCF5C62B Q38515906-32F909F9-A008-4FBE-B30B-A6DB48A5DD5D Q38543695-D9FEEC4E-CABD-4EEA-BAF8-B6717C068A61 Q38693820-A4A4C52D-145C-4900-AB99-31BAA65FB26C Q38759266-341CD725-8CD8-42BB-968F-23734C1AFB3E Q38912794-C3282F79-1724-42BC-A092-F10591C9FE52 Q40153096-C97C27E6-F90C-4153-AEE1-CBAE1E3C0084 Q40280603-2C61AF3D-0497-480A-9B0B-82AB2AED74DC Q40483611-8B841AF3-E4C7-4E5D-AED7-F23857DAA5F9 Q40873991-8D121FF5-6E78-4DDD-BB67-F80B785023F9 Q40946051-639A6D1D-DE20-495B-B318-232C887DB4B9 Q42205223-54E46197-9A7A-45C3-B3F3-08AF5EA5A878 Q49853233-DCF476C9-36D3-4659-88DB-4F8F38542C84 Q54243856-A0498DAE-972C-4E4F-ADE3-07E48B6D238B Q57821930-5491AAE0-64CA-4DCA-B697-D1D528F09B93

P2860

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

http://www.wikidata.org/entity/Q37604517

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

@en

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

@nl

type

label

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

@en

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

@nl

prefLabel

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

@en

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

@nl

P1433

Q37604517-AEF0EB23-73DA-4A7A-B3CB-3FEDE2990274

P1476

Q37604517-FA4A5268-B59A-45C2-8B9F-5056C9185992

P2093

Q37604517-1C22CFC0-3771-4FBE-BE7C-18AC417EDE38

Q37604517-297ECBE2-D1B4-4AEE-9BFE-2C03A190C317

Q37604517-4824DE6F-2C1C-4C3D-A0AE-AC7FBC1268BF

Q37604517-525ED3DB-6082-4D5D-9E96-8E1B658BB0D7

Q37604517-6D60F391-A5F3-431E-BAF5-22D940325F72

Q37604517-82A2A7D1-AF3A-4A77-B85D-2C12F0CE4B3C

Q37604517-B5597BAD-94A7-44D1-B2F6-48ADC15B31C3

Q37604517-CDECEC5C-3C14-47EF-86D4-A2054F44E91C

Q37604517-F8493A81-9F7C-4A06-B8CA-DC8E921AE0C9

P2860

Q37604517-07CBFBC3-AEC7-4D29-8C1F-DFE43BA370BA

Q37604517-0E0403A6-EA24-43EF-86E4-EB9D97D533FF

Q37604517-13A468B6-CE15-40FF-A4B8-41EDE35FBFB8

Q37604517-1578C3BD-CCEF-44DB-AE16-788846FFBD7D

Q37604517-1C65B0EB-9E35-43C5-BFCA-E7448814ABA2

Q37604517-24A5B5C7-7E9A-4F5C-B544-25238AC17AC3

Q37604517-265BBD96-00EF-4765-BA36-154C6E74EB1A

Q37604517-2FF9A683-46E5-418C-99C4-4B1B34F4643E

Q37604517-3BCE52B9-0493-429C-ACC0-A360B9BF1AEB

Q37604517-44E4CBCC-1770-43BB-86AD-4B428290494E

P304

Q37604517-0A5C6CF1-AFB8-4D7D-B2A7-22340E72E6DE

P31

Q37604517-ACE947C4-35F8-405A-A934-627045ABA767

P356

Q37604517-9263F63C-7C1F-4032-B3A4-3DE0B78ACDC8

P407

Q37604517-A97E8C38-E763-4B39-8A18-A9620C517B9C

P433

Q37604517-686ACD35-A8AD-40F3-B1EC-D2B40B102B85

P478

Q37604517-36148D0D-5FBE-49DB-A7EA-E131E30C5441

P50

Q37604517-EA09412A-C72C-4249-9B08-E5CB1295082B

P577

Q37604517-5B25692B-0BD6-4FFA-81D3-CD5B4CBAA0E8

P5875

Q37604517-F5512842-A83A-4443-8C06-CA1D0D4A6409

P698

Q37604517-54EBC447-981E-436B-9EFE-E0FC26D62086

P921

Q37604517-C1092116-56B3-47B3-B4E0-5D2E993D111C

P932

Q37604517-032DBACE-5976-41E2-A7C2-8ECB3AC6B317

P356

P1433

Clinical Infectious Diseases

P1476

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men

@en

P2093

Alison J Uriel

http://www.w3.org/2001/XMLSchema#string

Andrea D Branch

http://www.w3.org/2001/XMLSchema#string

Damaris C Carriero

http://www.w3.org/2001/XMLSchema#string

David G Cassagnol

http://www.w3.org/2001/XMLSchema#string

Douglas T Dieterich

http://www.w3.org/2001/XMLSchema#string

Michael P Mullen

http://www.w3.org/2001/XMLSchema#string

New York Acute Hepatitis C Surveillance Network

http://www.w3.org/2001/XMLSchema#string

Rosanne M Hijdra

http://www.w3.org/2001/XMLSchema#string

Wouter O van Seggelen

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco.

Clinical presentation and course of acute hepatitis C infection in HIV-infected patients.

Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C

Rare birds in North America: acute hepatitis C cohorts

Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection.

P304

873-879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIT799

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Daniel S. Fierer

P577

2013-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262045679

http://www.w3.org/2001/XMLSchema#string

P698

24336914

http://www.w3.org/2001/XMLSchema#string

P921

P932

3935497

http://www.w3.org/2001/XMLSchema#string